【レポートの概要（一部）】
Table of Contents
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Biologics Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market Driver Analysis
3.1.1.1 Advancements in biomedical science
3.1.1.2 Rise in biologics contract manufacturing services
3.1.1.3 Several drugs going off patents
3.1.1.4 Commercial success of biologics
3.1.2 Market Restraint Analysis
3.1.2.1 Pharmacokinetics challenges associated with biologics
3.1.2.2 Rising control & cost for accessing biologics
3.1.2.3 Development of biosimilars
3.2 Penetration & Growth Prospect Mapping for Product, 2016
3.3 Biologics -Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis – Porter’s
3.5 Biologics: Pipeline Analysis
Chapter 4 Biologics Market: Source Estimates & Trend Analysis
4.1 Global Biologics Market: Source Movement Analysis
4.2 Microbial Source
4.2.1 Global microbial source market, 2014 – 2025 (USD Billion)
4.3 Mammalian Source
4.3.1 Global mammalian source market, 2014 – 2025 (USD Billion)
4.4 Others
4.4.1 Global other source market, 2014 – 2025 (USD Billion)
Chapter 5 Biologics Market: Product Estimates & Trend Analysis
5.1 Global Biologics Market: Product Movement Analysis
5.2 Monoclonal Antibodies
5.2.1 Global monoclonal antibodies market, 2014 – 2025 (USD Billion)
5.2.2 Monoclonal antibodies by application
5.2.2.1 Diagnostic monoclonal antibodies
5.2.2.1.1 Diagnostic MABs market, 2014 – 2025 (USD Billion)
5.2.2.1.2 Diagnostic MABs for biochemical analysis
5.2.2.1.3 Diagnostic MABs for imaging
5.2.2.2 Therapeutic MABs
5.2.2.2.1 Therapeutic MABs market, 2014 – 2025 (USD Billion)
5.2.2.2.2 Direct MABs
5.2.2.2.3 Targeting MABs
5.2.2.3 Protein purification MABs
5.2.2.3.1 Protein purification MABs market, 2014 – 2025 (USD Billion)
5.2.2.4 Other MABs
5.2.2.4.1 Other MABs market, 2014 – 2025 (USD Billion)
5.2.3 Monoclonal antibodies by type
5.2.3.1 Murine MABs
5.2.3.1.1 Murine MABs market, 2014 – 2025 (USD Billion)
5.2.3.2 Chimeric MABs
5.2.3.2.1 Chimeric MABs market, 2014 – 2025 (USD Billion)
5.2.3.3 Humanized MABs
5.2.3.3.1 Humanized MABs market, 2014 – 2025 (USD Billion)
5.2.3.4 Human MABs
5.2.3.4.1 Human MABs market, 2014 – 2025 (USD Billion)
5.2.3.5 Other MABs
5.2.3.5.1 Other MABs market, 2014 – 2025 (USD Billion)
5.3 Vaccines
5.3.1 Global vaccines market, 2014 – 2025 (USD Billion)
5.4 Recombinant Proteins
5.4.1 Global recombinant proteins market, 2014 – 2025 (USD Billion)
5.5 Antisense, RNAi & Molecular Therapy
5.5.1 Global antisense, RNAi & molecular therapy market, 2014 – 2025 (USD Billion)
5.6 Others
5.6.1 Global other product market, 2014 – 2025 (USD Billion)
Chapter 6 Biologics Market: Manufacturing Estimates & Trend Analysis
6.1 Global Biologics Market: Manufacturing Movement Analysis
6.2 Outsourced
6.2.1 Global outsourced market, 2014 – 2025 (USD Billion)
6.3 In-house
6.3.1 Global in-house market, 2014 – 2025 (USD Billion)
Chapter 7 Biologics Market: Disease Category Estimates & Trend Analysis
7.1 Global Biologics Market: Disease Category Movement Analysis
7.2 Oncology
7.2.1 Global oncology market, 2014 – 2025 (USD Billion)
7.2.2 MABs market for oncology
7.2.2.1 Global MABs market for oncology, 2014 – 2025 (USD Billion)
7.2.3 Vaccines market for oncology
7.2.3.1 Global vaccines market for oncology, 2014 – 2025 (USD Billion)
7.2.4 Recombinant proteins market for oncology
7.2.4.1 Global recombinant proteins market for oncology, 2014 – 2025 (USD Billion)
7.2.5 Antisense, RNAi, & molecular therapy market for oncology
7.2.5.1 Global antisense, RNAi, & molecular therapy market for oncology, 2014 – 2025 (USD Billion)
7.2.6 Other products market for oncology
7.2.6.1 Global products market for oncology, 2014 – 2025 (USD Billion)
7.3 Infectious Disease
7.3.1 Global infectious disease market, 2014 – 2025 (USD Billion)
7.3.2 Vaccines market for infectious disease
7.3.2.1 Global vaccines market for infectious disease, 2014 – 2025 (USD Billion)
7.3.3 MABs market for infectious disease
7.3.3.1 Global MABs market for infectious disease, 2014 – 2025 (USD Billion)
7.3.4 Antisense, RNAi, & molecular therapy market for infectious disease
7.3.4.1 Global antisense, RNAi, & molecular therapy market for infectious disease, 2014 – 2025 (USD Billion)
7.3.5 Recombinant proteins market for infectious disease
7.3.5.1 Global recombinant proteins market for infectious disease, 2014 – 2025 (USD Billion)
7.3.6 Other products market for infectious disease
7.3.6.1 Global products market for infectious disease, 2014 – 2025 (USD Billion)
7.4 Immunological Disorders
7.4.1 Global immunological disorders market, 2014 – 2025 (USD Billion)
7.5 Cardiovascular disorders
7.5.1 Global cardiovascular disorders market, 2014 – 2025 (USD Billion)
7.6 Hematologic Disorders
7.6.1 Global hematologic disorders market, 2014 – 2025 (USD Billion)
7.7 Others
7.7.1 Global other indications market, 2014 – 2025 (USD Billion)
Chapter 8 Biologics Market: Regional Estimates & Trend Analysis, by Source, Product, Manufacturing, & Disease Category
8.1 Biologics Market Share By Region, 2015 & 2025
8.2 North America
8.2.1 North America biologics market, 2014 – 2025 (USD Billion)
8.2.2 U.S.
8.2.2.1 U.S. biologics market, 2014 – 2025 (USD Billion)
8.2.3 Canada
8.2.3.1 Canada biologics market, 2014 – 2025 (USD Billion)
8.3 Europe
8.3.1 Europe biologics market, 2014 – 2025 (USD Billion)
8.3.2 Germany
8.3.2.1 Germany biologics market, 2014 – 2025 (USD Billion)
8.3.3 UK
8.3.3.1 UK biologics market, 2014 – 2025 (USD Billion)
8.4 Asia Pacific
8.4.1 Asia Pacific biologics market, 2014 – 2025 (USD Billion)
8.4.2 Japan
8.4.2.1 Japan biologics market, 2014 – 2025 (USD Billion)
8.4.3 China
8.4.3.1 China biologics market, 2014 – 2025 (USD Billion)
8.5 Latin America
8.5.1 Latin America biologics market, 2014 – 2025 (USD Billion)
8.5.2 Brazil
8.5.2.1 Brazil biologics market, 2014 – 2025 (USD Billion)
8.6 Middle East & Africa (MEA)
8.6.1 Middle East & Africa biologics market, 2014 – 2025 (USD Billion)
8.6.2 South Africa
8.6.2.1 South Africa biologics market, 2014 – 2025 (USD Billion)
Chapter 9 Competitive Landscape
9.1 Strategy Framework
9.2 Market Participation Categorization
9.3 Company Profiles
9.3.1 Samsung BioLogics
9.3.1.1 Company overview
9.3.1.2 Financial performance
9.3.1.3 Product benchmarking
9.3.1.4 Strategic initiatives
9.3.2 Amgen
9.3.2.1 Company overview
9.3.2.2 Financial performance
9.3.2.3 Product benchmarking
9.3.2.4 Strategic initiatives
9.3.3 Novo Nordisk A/S
9.3.3.1 Company overview
9.3.3.2 Financial performance
9.3.3.3 Product benchmarking
9.3.3.4 Strategic initiatives
9.3.4 AbbVie Inc.
9.3.4.1 Company overview
9.3.4.2 Financial performance
9.3.4.3 Product benchmarking
9.3.4.4 Strategic initiatives
9.3.5 Sanofi
9.3.5.1 Company overview
9.3.5.2 Financial performance
9.3.5.3 Product benchmarking
9.3.5.4 Strategic initiatives
9.3.6 Johnson & Johnson Services, Inc
9.3.6.1 Company overview
9.3.6.2 Financial performance
9.3.6.3 Product benchmarking
9.3.6.4 Strategic initiatives
9.3.7 Pfizer Inc.
9.3.7.1 Company overview
9.3.7.2 Financial performance
9.3.7.3 Product benchmarking
9.3.7.4 Strategic initiatives
9.3.8 Merck & Co., Inc.
9.3.8.1 Company overview
9.3.8.2 Financial performance
9.3.8.3 Product benchmarking
9.3.9 GSK group of companies
9.3.9.1 Company overview
9.3.9.2 Financial performance
9.3.9.3 Product benchmarking
9.3.9.4 Strategic initiatives
9.3.10 Celltrion
9.3.10.1 Company overview
9.3.10.2 Financial performance
9.3.10.3 Product benchmarking
9.3.10.4 Strategic initiatives
9.3.11 Precision Biologics, Inc.
9.3.11.1 Company overview
9.3.11.2 Financial performance
9.3.11.3 Product benchmarking
9.3.11.4 Strategic initiatives
9.3.12 Merck KGaA
9.3.12.1 Company overview
9.3.12.2 Financial performance
9.3.12.3 Product benchmarking
9.3.12.4 Strategic initiatives
9.3.13 Eli Lilly and Company
9.3.13.1 Company overview
9.3.13.2 Financial performance
9.3.13.3 Product benchmarking
9.3.14 Novartis AG
9.3.14.1 Company overview
9.3.14.2 Financial performance
9.3.14.3 Product benchmarking
9.3.14.4 Strategic initiatives
9.3.15 Bayer AG
9.3.15.1 Company overview
9.3.15.2 Financial performance
9.3.15.3 Product benchmarking
9.3.15.4 Strategic initiatives
9.3.16 F. Hoffmann-La Roche Ltd
9.3.16.1 Company overview
9.3.16.2 Financial performance
9.3.16.3 Product benchmarking
9.3.16.4 Strategic initiatives
9.3.17 AstraZeneca
9.3.17.1 Company overview
9.3.17.2 Financial performance
9.3.17.3 Product benchmarking
9.3.17.4 Strategic initiatives
【レポート販売概要】
■ タイトル：生物製剤の世界市場分析：由来別（微生物、哺乳類）、製品別（モノクローナル抗体、ワクチン、組換えタンパク質、アンチセンス、RNAi、分子治療）、病気の種類別、製造法別、セグメント予測、2014-2025■ 英文：Biologics Market Analysis By Source (Microbial, Mammalian), By Products (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi, & Molecular Therapy), By Disease Category, By Manufacturing, And Segment Forecasts, 2014-2025
■ 発行日：2017年3月1日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707122
■ 調査対象地域：グローバル
- Rabies：グローバル臨床試験レビューH2, 2013Rabies Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Rabies Global Clinical Trials Review, H2, 2013" provides data on the Rabies clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Rabies. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction ac …
- 減摩軸受の世界市場：玉軸受、ころ軸受About Anti-friction Bearings Anti-friction bearings are mechanical devices employed to reduce friction between rotating equipment. Based on construction, anti-friction bearings are mainly classified into small- and large-bore ball and roller bearings. Roller bearings are further classified into needle, cylindrical, spherical, and tapered roller bearings. Technavio's analysts forecast the global an …
- 化学機械平坦化（CMP）の世界市場：研磨装置、研磨消耗品Chemical mechanical planarization (CMP) is an enabling technology in the wafer fabrication of integrated circuits and has been widely used in the wafer manufacturing process in different electronic devices such as semiconductors, optoelectronics, and optics for reducing chip size & improving performance. Continuous research & development efforts and associated technological breakthroughs in the ar …
- アンモニアの世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world ammonia market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true insight i …
- グローバル・エネルギー産業サーベイ（2013-2014）：市場動向、マーケティング戦略Why was the report written? This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading global power industry executives. The report provides data and analysis on global power industry suppliers’ media spend, marketing and sales strategies, and practices and business planning within the global power industry. This report includes key topics such as media c …
- 2014年戦略提言：スペインの薬物乱用検査市場This new 260-page report from Venture Planning Group provides a comprehensive analysis of the Spanish drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antide …
- 経カテーテル的僧帽弁置換術の世界市場2016-2020About Mitral Valve The mitral valve manages blood flow from the left atrium to the left ventricle. The valve prevents the backward flow of the blood. Mitral regurgitation is a common mitral valve disorder that causes the abnormal backward flow of the blood. Cardiologists use mitral surgical valve repair procedures or transcatheter replacement procedures to treat this disorder. About 80,000 individ …
- ドイツの診断市場：：市場動向と展望This new report from Venture Planning Group provides an overview of the German diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: - Blood Banking - Cancer - Chemistry &nb …
- Woodside Petroleum Limited：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Woodside Petroleum Limited Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Woodside Petroleum Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essent …
- 世界主要国におけるクリプトスポリジウム検査市場2015The report presents a detailed analysis of the Cryptosporidium diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Cryptosporidium definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals …
- 世界の石油増進回収市場：Global Enhanced Oil Recovery (EOR) Market 2014-2018TechNavio forecasts The Global Enhanced Oil Recovery Market 2014-2018 with a CAGR of 28.7 percent for the period 2013-2018. Several driving factors and trends will contribute to this growth-all of which will be outlined with detail in this report. TechNavio’s analysts use a unique methodology to scrutinize individual vendor performance, trends, drivers and challenges, and a number of other factors …
- 医療用コーディングの世界市場：分類システム別（国際疾病分類（ICD）、ヘルスケア共通プロシージャコーディングシステム（HCPCS））、コンポーネント別（インハウス、アウトソーシング）、地域別予測Global Medical Coding Market valued approximately USD xxxx billion in 2016 is anticipated to grow with a healthy growth rate of more than xx% over the forecast Rising need for a universal language in medical documents in order to streamline hospital billing procedures is driving the growth of the market. Rising occurrence of insurance frauds and insurance issues associated with misinterpretation o …
- ヨーロッパのガラス市場About glass Glass is produced from raw materials such as high-quality sand (silica), limestone, soda ash, and cullet (crushed recycled glass). The glass industry is mainly divided into three sectors: flat glass manufacturing, container glass manufacturing, and fiberglass production. This industry (in comparison to other commercial and industrial sectors) was influenced by economic crisis in the la …
- 可視光通信（VLC）の世界市場2015-2019Technavio expects the global visible light communication (VLC) market to grow at a very optimistic rate, posting a CAGR of almost 64% during the forecast period. Visible light communication is a wireless technology that uses light emanated by LED bulbs to provide a network for high-speed communication parallel to Wi-Fi. This technology is a faster and cheaper optical version of Wi-Fi. The market g …
- 世界のクラウドサービス仲介市場動向（2014-2018）TechNavio's analysts forecast the Global Cloud Services Brokerage market to grow at a CAGR of 45.90 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing complexity in integrating cloud-based solutions with enterprise computing infrastructure. The Global Cloud Services Brokerage market has also been witnessing the standardization of cloud-ba …
